Thermo Fisher Scientific EPS - Earnings per Share 2010-2024 | TMO

Thermo Fisher Scientific earnings per share (EPS) for the twelve months ending September 30, 2024 was $15.95, a 4.52% increase year-over-year.

  • Thermo Fisher Scientific EPS for the quarter ending September 30, 2024 was $4.25, a 3.85% decline year-over-year.
  • Thermo Fisher Scientific 2023 annual EPS was $15.45, a 12.37% decline from 2022.
  • Thermo Fisher Scientific 2022 annual EPS was $17.63, a 9.4% decline from 2021.
  • Thermo Fisher Scientific 2021 annual EPS was $19.46, a 21.93% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Thermo Fisher Scientific EPS - Earnings per Share 2010-2024 | TMO

  • Thermo Fisher Scientific EPS for the quarter ending September 30, 2024 was $4.25, a 3.85% decline year-over-year.
  • Thermo Fisher Scientific 2023 annual EPS was $15.45, a 12.37% decline from 2022.
  • Thermo Fisher Scientific 2022 annual EPS was $17.63, a 9.4% decline from 2021.
  • Thermo Fisher Scientific 2021 annual EPS was $19.46, a 21.93% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$191.9B
Alcon (ALC)$42.1B
Edwards Lifesciences (EW)$41.4B
IQVIA Holdings (IQV)$34.7B
IDEXX Laboratories (IDXX)$34.1B
DexCom (DXCM)$29.2B
STERIS (STE)$20.9B
Waters (WAT)$20.5B
SONOVA HOLDING (SONVY)$20.3B
Hologic (HOLX)$18.2B
Fresenius Medical Care AG KGaA (FMS)$13B
Sysmex ADR (SSMXY)$12.7B
Globus Medical (GMED)$11.3B
Penumbra (PEN)$9.1B
Teleflex (TFX)$9B
Masimo (MASI)$8.8B
Glaukos (GKOS)$8B
PROCEPT BioRobotics (PRCT)$4.9B
Integer Holdings (ITGR)$4.5B
Veracyte (VCYT)$3B
Inari Medical (NARI)$3B
LivaNova (LIVN)$2.8B
TransMedics (TMDX)$2.8B
Nihon Kohden (NHNKY)$2.3B
Elekta AB (EKTAY)$2.2B
Tandem Diabetes Care (TNDM)$1.8B
RxSight (RXST)$1.8B
Integra LifeSciences Holdings (IART)$1.8B
Alphatec Holdings (ATEC)$1.4B
Artivion (AORT)$1.1B